Explore 3 Stock Ideas & Industry Insights Download Free Report

Haoxi Health Technology Limited

Company price
1.92 USD 0.07 ( 3.78%)
Last update at 2026-11-06T21:00:00Z
VOLUME
3493
Market Cap
1.03M

Momentum Score

…

Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. It serves advertiser client base primarily in the healthcare industry. Haoxi Health Technology Limited was founded in 2018 and is based in Chaoyang, China.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
1.83
Low
1.93
High
52 Week Price Range
2.61
Low
4352.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Haoxi Health Technology Limited is a NASDAQ-listed company that describes itself as operating in health technology, but public filings provide limited detail on its products, markets, and financials. If its stated focus holds, long-term growth drivers could include aging demographics, rising healthcare spending and digital-health adoption in China, which may support demand and make the company attractive to investors seeking healthcare exposure.
Key risks are limited disclosure and transparency, Chinese regulatory and compliance uncertainty, thin stock liquidity and small-cap execution or financing risk.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
1.85
Dividend Yield
-
Revenue TTM
42.68M
Revenue Per Share
1202.80
Gross Profit TTM
2.04M
Debt / Equity
0.11
ROE
-15.98%
Net Debt
-6.62M
ROCE
23.68%
Diluted EPS TTM
-297.86

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 4.15M 1.74M 1.74M 1.19M 0.26M
Net income 3.88M 1.29M 1.29M 0.97M 0.24M
Selling general administrative - 0.91M 0.95M 0.81M 0.28M
Selling and marketing expenses - 0.04M - - -
Gross profit 0.93M 2.75M 2.75M 2.06M 0.65M
Reconciled depreciation - - 0.01M 0.01M 0.00M
Ebit 4.19M 1.78M - - -
Ebitda 4.57M 1.79M 2.75M - -
Depreciation and amortization 0.37M 0.01M - - -
Operating income -2.00M 1.72M 2.75M 1.20M 0.27M
Other operating expenses 34.80M 46.80M 45.77M - -
Interest expense 0.05M 0.04M 0.04M 0.02M 0.01M
Tax provision - - 0.44M 0.22M 0.02M
Interest income - - 0.08M - -
Net interest income - - 0.03M -0.02M -0.01M
Income tax expense 0.27M 0.44M -1.29M - -
Total revenue 32.80M 48.52M 48.52M 28.23M 16.16M
Total operating expenses 2.93M 1.03M 46.80M 27.03M 15.89M
Cost of revenue 31.88M 45.77M 45.77M 26.17M 15.51M
Total other income expense net 6.15M 0.02M -2.75M 0.02M 0.00M
Net income from continuing ops - - 1.29M 0.97M 0.24M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 21.60M 15.51M 15.51M 4.46M 0.54M
Intangible assets 1.80M - - - -
Other current assets 5.70M 5.17M - - -
Total liab 4.22M 4.23M 4.23M 2.90M 2.01M
Total stockholder equity 17.38M 11.27M 11.27M 1.57M -1.47M
Other current liab 1.51M 0.20M - - -
Common stock 0.01M 0.00M - - -
Capital stock - - 0.00M 0.00M 0.00M
Retained earnings 4.60M 0.72M 0.72M -0.57M -1.54M
Cash 8.62M 6.66M 6.66M 1.20M 0.29M
Total current liabilities 3.89M 3.87M 3.87M 2.58M 2.01M
Current deferred revenue 0.54M 1.19M - - -
Net debt -6.62M -5.45M - - 0.15M
Short term debt 1.69M 0.78M - - -
Short long term debt - - 0.83M 0.51M 0.44M
Short long term debt total 1.99M 1.20M - - -
Other stockholder equity 12.81M 10.59M - - -
Total current assets 19.60M 15.38M 15.38M 3.67M 0.45M
Net receivables 5.29M 3.55M 0.23M 0.01M 0.00M
Long term debt - - 0.37M 0.25M -
Inventory - 5.17M - - -
Accounts payable 0.15M 0.65M 0.65M 0.05M 1.27M
Accumulated other comprehensive income -0.05M -0.04M - - -
Non current assets total 1.99M 0.13M 0.13M 0.79M 0.10M
Capital lease obligations - - 0.00M 0.09M 0.07M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - - -3.13M -0.05M -0.01M
Total cashflows from investing activities -3.58M -3.13M - - -
Net borrowings - - 0.36M - -
Total cash from financing activities 8.90M 9.32M 9.32M 1.80M 0.93M
Net income 3.88M 1.29M 1.29M 0.97M 0.24M
Change in cash 1.96M 5.45M 5.45M 0.91M 0.24M
Begin period cash flow 6.66M 1.20M 1.20M 0.29M 0.06M
End period cash flow 8.62M 6.66M 6.66M 1.20M 0.29M
Total cash from operating activities -3.36M -0.75M -0.75M -0.87M -0.68M
Issuance of capital stock - - 8.98M 1.99M 0.16M
Depreciation 0.37M 0.01M 0.01M 0.01M 0.00M
Other cashflows from investing activities -1.50M -3.07M - - -
Change to account receivables -0.25M -0.22M -0.22M -0.00M 0.67M
Other cashflows from financing activities - -0.01M - - -
Capital expenditures 0.00M 0.06M 0.06M 0.05M 0.01M
Change in working capital -1.84M -2.05M -2.05M -1.85M -0.76M
Other non cash items -5.76M - - - -0.16M
Free cash flow -3.36M -0.80M -0.80M -0.92M -0.68M

Peer Comparison*

Sector: Communication Services Industry: Advertising Agencies

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
HAO
Haoxi Health Technology Limited
0.07
3.78%
1.92 - - 0.02 0.06 0.89 13.53
APP
Applovin Corp
35.54
9.98%
391.64 49.00 31.75 30.27 77.57 30.41 38.27
PGPEF
Publicis Groupe S.A
-
-%
109.60 15.93 11.57 1.55 2.24 1.76 9.39
PUBGY
Publicis Groupe SA
-0.65
2.22%
28.62 16.35 11.74 1.57 2.27 1.76 9.39
OMC
Omnicom Group Inc
-0.72
0.83%
86.37 12.68 11.89 1.17 5.11 1.58 9.50

Profile*

Haoxi Health Technology Limited

Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. It serves advertiser client base primarily in the healthcare industry. Haoxi Health Technology Limited was founded in 2018 and is based in Chaoyang, China.

Tower C, Building 103, Chaoyang, China

86 10 13311 587976

26

Name Title Year Born
Mr. Lei Xu Founder, COO & Director 1988
Ms. Dongxue Li Chief Financial Officer 1987

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…